Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 66.95% this year. Over the last six months, there has been a weaker performance of 44.17%. The price of TEVA fallen by 1.93% during the last 30 days period. For the last 5-days stocks have improved 2.59%.
Teva- Pharmaceutical Industries Ltd. ADR’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $18.02 on 07/31/24, with the lowest value being $8.06 on 10/23/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TEVA Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -3.30% away from its 52-week high, while its distance from the 52-week low is 116.39%. The stock’s price range over this timeframe has been between $8.06 and $18.02. The shares of the Healthcare sector company recorded a trading volume of approximately 7.33 million for the day, which was comparatively lower than the average daily volume of 9.91 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 8.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.74B and boasts a workforce of 37226 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.69, with a change in price of +4.11. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 9,782,459 in trading volume during the last 100 days, posting a change of +30.86%.
TEVA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TEVA stands at 2.98. Similarly, the long-term debt-to-equity ratio is also 2.65.
TEVA Stock Stochastic Average
The raw stochastic average for Teva- Pharmaceutical Industries Ltd. ADR over the last 50 days is presently at 75.26%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 73.14%. Further, the company’s Stochastic %K and %D values for the last 20 days were 59.44% and 52.19%, respectively.
